
Aiden Y. Lee
Examiner (ID: 746, Phone: (571)270-1440 , Office: P/1718 )
| Most Active Art Unit | 1718 |
| Art Unit(s) | 1718, 1713 |
| Total Applications | 525 |
| Issued Applications | 210 |
| Pending Applications | 69 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9166784
[patent_doc_number] => 08592462
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-26
[patent_title] => 'Pirfenidone treatment for patients with atypical liver function'
[patent_app_type] => utility
[patent_app_number] => 13/312746
[patent_app_country] => US
[patent_app_date] => 2011-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10370
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13312746
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/312746 | Pirfenidone treatment for patients with atypical liver function | Dec 5, 2011 | Issued |
Array
(
[id] => 8228563
[patent_doc_number] => 20120142770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELATABLE METAL COMPOUNDS, AND METAL-HDAC INHIBITOR CHELATE COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 13/297994
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 18168
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13297994
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/297994 | PHARMACEUTICAL COMPOSITIONS OF HDAC INHIBITORS AND CHELATABLE METAL COMPOUNDS, AND METAL-HDAC INHIBITOR CHELATE COMPLEXES | Nov 15, 2011 | Abandoned |
Array
(
[id] => 8477803
[patent_doc_number] => 20120277210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/282773
[patent_app_country] => US
[patent_app_date] => 2011-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 151373
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282773
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282773 | SOLID DISPERSIONS CONTAINING AN APOPTOSIS-INDUCING AGENT | Oct 26, 2011 | Abandoned |
Array
(
[id] => 7768029
[patent_doc_number] => 20120035185
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Method of Using Flibanserin for Neuroprotection'
[patent_app_type] => utility
[patent_app_number] => 13/276970
[patent_app_country] => US
[patent_app_date] => 2011-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2389
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20120035185.pdf
[firstpage_image] =>[orig_patent_app_number] => 13276970
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/276970 | Method of Using Flibanserin for Neuroprotection | Oct 18, 2011 | Abandoned |
Array
(
[id] => 7744563
[patent_doc_number] => 20120022105
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'GREASE-LIKE GEL FOR REPELLING RODENTS'
[patent_app_type] => utility
[patent_app_number] => 13/267728
[patent_app_country] => US
[patent_app_date] => 2011-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9425
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022105.pdf
[firstpage_image] =>[orig_patent_app_number] => 13267728
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/267728 | GREASE-LIKE GEL FOR REPELLING RODENTS | Oct 5, 2011 | Abandoned |
Array
(
[id] => 8241045
[patent_doc_number] => 20120149783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-14
[patent_title] => 'WATER-IN-OIL EMULSION COMPOSITIONS CONTAINING GELLAN GUM FOR TOPICAL DELIVERY OF ACTIVE INGREDIENTS TO THE SKIN OR MUCOSA'
[patent_app_type] => utility
[patent_app_number] => 13/253594
[patent_app_country] => US
[patent_app_date] => 2011-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4132
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13253594
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/253594 | Water-in-oil emulsion compositions containing gellan gum for topical delivery of active ingredients to the skin or mucosa | Oct 4, 2011 | Issued |
Array
(
[id] => 7754747
[patent_doc_number] => 20120027818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'BISPHOSPHONATE PRODUCT IN A CYCLOOLEFINIC POLYMER CONTAINER'
[patent_app_type] => utility
[patent_app_number] => 13/242613
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6836
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027818.pdf
[firstpage_image] =>[orig_patent_app_number] => 13242613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/242613 | BISPHOSPHONATE PRODUCT IN A CYCLOOLEFINIC POLYMER CONTAINER | Sep 22, 2011 | Abandoned |
Array
(
[id] => 8417707
[patent_doc_number] => 20120245202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'METHODS AND PRODUCTS FOR TREATING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/235860
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 66
[patent_figures_cnt] => 66
[patent_no_of_words] => 52001
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13235860
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/235860 | METHODS AND PRODUCTS FOR TREATING INFLAMMATION | Sep 18, 2011 | Abandoned |
Array
(
[id] => 8324505
[patent_doc_number] => 20120196899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'METHODS AND PRODUCTS FOR TREATING INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/235893
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 51713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13235893
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/235893 | METHODS AND PRODUCTS FOR TREATING INFLAMMATION | Sep 18, 2011 | Abandoned |
Array
(
[id] => 7663621
[patent_doc_number] => 20110312890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS'
[patent_app_type] => utility
[patent_app_number] => 13/195229
[patent_app_country] => US
[patent_app_date] => 2011-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18172
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312890.pdf
[firstpage_image] =>[orig_patent_app_number] => 13195229
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/195229 | ACETYLATED AMINO ACIDS AS ANTI-PLATELET AGENTS, NUTRITIONAL AND VITAMIN SUPPLEMENTS | Jul 31, 2011 | Abandoned |
Array
(
[id] => 9608318
[patent_doc_number] => 08785485
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Animal ectoparasite-controlling agent'
[patent_app_type] => utility
[patent_app_number] => 13/194062
[patent_app_country] => US
[patent_app_date] => 2011-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28593
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13194062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/194062 | Animal ectoparasite-controlling agent | Jul 28, 2011 | Issued |
Array
(
[id] => 9086375
[patent_doc_number] => 08557804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Nicotinic receptor agonists for the treatment of inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 13/190941
[patent_app_country] => US
[patent_app_date] => 2011-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 41
[patent_no_of_words] => 16794
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13190941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/190941 | Nicotinic receptor agonists for the treatment of inflammatory diseases | Jul 25, 2011 | Issued |
Array
(
[id] => 9086375
[patent_doc_number] => 08557804
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Nicotinic receptor agonists for the treatment of inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 13/190941
[patent_app_country] => US
[patent_app_date] => 2011-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 41
[patent_no_of_words] => 16794
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13190941
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/190941 | Nicotinic receptor agonists for the treatment of inflammatory diseases | Jul 25, 2011 | Issued |
Array
(
[id] => 9074406
[patent_doc_number] => 08551983
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Nicotinic receptor agonists for the treatment of inflammatory diseases'
[patent_app_type] => utility
[patent_app_number] => 13/178670
[patent_app_country] => US
[patent_app_date] => 2011-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 41
[patent_no_of_words] => 16793
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13178670
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/178670 | Nicotinic receptor agonists for the treatment of inflammatory diseases | Jul 7, 2011 | Issued |
Array
(
[id] => 8866667
[patent_doc_number] => 20130150370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'TASTE-MASKED PHARMACEUTICAL FORMULATION HAVING ACCELERATED ONSET OF ACTION'
[patent_app_type] => utility
[patent_app_number] => 13/805587
[patent_app_country] => US
[patent_app_date] => 2011-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2531
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13805587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/805587 | TASTE-MASKED PHARMACEUTICAL FORMULATION HAVING ACCELERATED ONSET OF ACTION | Jun 23, 2011 | Abandoned |
Array
(
[id] => 10089093
[patent_doc_number] => 09125899
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-09-08
[patent_title] => 'Modulators of GTPases and their use'
[patent_app_type] => utility
[patent_app_number] => 13/161766
[patent_app_country] => US
[patent_app_date] => 2011-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 10
[patent_no_of_words] => 23080
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13161766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/161766 | Modulators of GTPases and their use | Jun 15, 2011 | Issued |
Array
(
[id] => 7490510
[patent_doc_number] => 20110237603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'COMPOSITIONS OF AZIMILIDE DIHYDROCHLORIDE'
[patent_app_type] => utility
[patent_app_number] => 13/156810
[patent_app_country] => US
[patent_app_date] => 2011-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7523
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237603.pdf
[firstpage_image] =>[orig_patent_app_number] => 13156810
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/156810 | COMPOSITIONS OF AZIMILIDE DIHYDROCHLORIDE | Jun 8, 2011 | Abandoned |
Array
(
[id] => 9059994
[patent_doc_number] => 08546430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Thalidomide analogs'
[patent_app_type] => utility
[patent_app_number] => 13/153355
[patent_app_country] => US
[patent_app_date] => 2011-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21408
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13153355
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/153355 | Thalidomide analogs | Jun 2, 2011 | Issued |
Array
(
[id] => 8733736
[patent_doc_number] => 20130079305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => '3-SUBSTITUTED VINYLBORONATES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/700766
[patent_app_country] => US
[patent_app_date] => 2011-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11761
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13700766
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/700766 | 3-SUBSTITUTED VINYLBORONATES AND USES THEREOF | May 30, 2011 | Abandoned |
Array
(
[id] => 7670716
[patent_doc_number] => 20110319985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-29
[patent_title] => 'METHODS AND APPARATUS FOR LOCALIZED ADMINISTRATION OF INHIBITORY MOIETIES TO A PATIENT'
[patent_app_type] => utility
[patent_app_number] => 13/113793
[patent_app_country] => US
[patent_app_date] => 2011-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 26202
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13113793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/113793 | METHODS AND APPARATUS FOR LOCALIZED ADMINISTRATION OF INHIBITORY MOIETIES TO A PATIENT | May 22, 2011 | Abandoned |